Prematurity, atopy, and childhood asthma in Puerto Ricans

Christian Rosas-Salazar1, Sima K Ramratnam1, John M Brehm1

  • 1Division of Pediatric Pulmonary Medicine, Allergy and Immunology, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh, Pittsburgh, Pa.

Insights

Prematurity increases asthma risk in Puerto Rican children, especially those with atopy. This finding may help explain the high rates of atopic asthma in this population.

Area of Science:

  • Pediatric Allergy and Immunology
  • Neonatal Health
  • Epidemiology

Background:

  • Puerto Rican children experience high rates of prematurity and asthma.
  • Limited research exists on prematurity's impact on childhood asthma within this demographic.

Purpose of the Study:

  • To investigate the association between prematurity and asthma in Puerto Rican children.
  • To explore the role of atopy as a potential modifier in this relationship.

Main Methods:

  • A case-control study included 678 children (6-14 years) in San Juan, Puerto Rico.
  • Asthma defined by physician diagnosis and prior-year wheezing; prematurity by parental report.
  • Logistic regression analysis adjusted for key covariates, including atopy and environmental exposures.

Main Results:

  • A significant interaction was found between prematurity and atopy concerning asthma risk (P = .006).
  • Prematurity was linked to a nearly 5-fold increased odds of asthma in atopic children (aOR, 4.7; P = .007).
  • No significant association between prematurity and asthma was observed in nonatopic children.

Conclusions:

  • Atopy significantly modifies the association between prematurity and asthma in Puerto Rican children.
  • Prematurity may partially account for the elevated prevalence of atopic asthma in this ethnic group.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
360
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
73
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K